While experimental validation is needed to confirm these predicted NFκB binding sites and regulatory relationships, our study adds new data towards an understanding of the NFκB signaling pathway response to Gram-negative bacterial infection which may be applicable across mammalian species. This evidence concerns the gene NFKB1 and gram-negative bacterial infections.